InterMune Clinical Trials
Sponsors / InterMune
16 ClinicalTrials.gov entries name InterMune as the lead sponsor. Of these, 0 are recruiting, 0 are active without new recruitment, and 9 have completed. The registry records 6 terminated or withdrawn trials for InterMune. The most common reasons cited for termination include efficacy or futility findings. Planned participant enrollment across these trials sums to 3,476. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
16
Total Trials
0
Recruiting
0
Other Active
9
Completed
6
Terminated / Withdrawn
3,476
Total Enrollment
Termination reasons: Efficacy50% · Other50%
Recent Terminations
- Idiopathic Pulmonary Fibrosis"test drug showed lack of benefit at interim analysis"
- Idiopathic Pulmonary Fibrosis"program discontinued based on GIPF-007 results"
- Ovarian Carcinoma"futility"
- Non-Hodgkin's Lymphoma"administrative reasons"
- Lung Infection"Futility"
- Lung Disease"Study design changes were needed based on GIPF-001 results"